Charles Schwab Investment Management Inc Incyte Corp Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,716,741 shares of INCY stock, worth $179 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,716,741
Previous 1,671,138
2.73%
Holding current value
$179 Million
Previous $114 Million
27.94%
% of portfolio
0.02%
Previous 0.02%
Shares
34 transactions
Others Institutions Holding INCY
# of Institutions
796Shares Held
205MCall Options Held
638KPut Options Held
635K-
Baker Bros. Advisors LP New York, NY30.7MShares$3.2 Billion21.24% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$2.22 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$2.08 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.45 Billion0.68% of portfolio
-
State Street Corp Boston, MA9.68MShares$1.01 Billion0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $23.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...